nodes	percent_of_prediction	percent_of_DWPC	metapath
Pyridostigmine—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.0853	0.126	CbGbCtD
Pyridostigmine—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.0802	0.119	CbGbCtD
Pyridostigmine—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.0802	0.119	CbGbCtD
Pyridostigmine—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.0726	0.107	CbGbCtD
Pyridostigmine—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.0726	0.107	CbGbCtD
Pyridostigmine—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.0626	0.0925	CbGbCtD
Pyridostigmine—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.0608	0.0898	CbGbCtD
Pyridostigmine—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.055	0.0812	CbGbCtD
Pyridostigmine—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.055	0.0812	CbGbCtD
Pyridostigmine—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.0527	0.0779	CbGbCtD
Pyridostigmine—Flatulence—Indinavir—acquired immunodeficiency syndrome	0.000843	0.00264	CcSEcCtD
Pyridostigmine—Hyperhidrosis—Nelfinavir—acquired immunodeficiency syndrome	0.000838	0.00262	CcSEcCtD
Pyridostigmine—Hyperhidrosis—Stavudine—acquired immunodeficiency syndrome	0.000835	0.00261	CcSEcCtD
Pyridostigmine—Epistaxis—Saquinavir—acquired immunodeficiency syndrome	0.000831	0.0026	CcSEcCtD
Pyridostigmine—Vertigo—Zidovudine—acquired immunodeficiency syndrome	0.000827	0.00258	CcSEcCtD
Pyridostigmine—Muscle spasms—Indinavir—acquired immunodeficiency syndrome	0.000823	0.00257	CcSEcCtD
Pyridostigmine—Alopecia—Efavirenz—acquired immunodeficiency syndrome	0.000821	0.00257	CcSEcCtD
Pyridostigmine—Hypoaesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000818	0.00256	CcSEcCtD
Pyridostigmine—Musculoskeletal discomfort—Nevirapine—acquired immunodeficiency syndrome	0.000815	0.00255	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Didanosine—acquired immunodeficiency syndrome	0.000814	0.00254	CcSEcCtD
Pyridostigmine—Loss of consciousness—Zidovudine—acquired immunodeficiency syndrome	0.000809	0.00253	CcSEcCtD
Pyridostigmine—Paraesthesia—Nevirapine—acquired immunodeficiency syndrome	0.000804	0.00251	CcSEcCtD
Pyridostigmine—Convulsion—Zidovudine—acquired immunodeficiency syndrome	0.000797	0.00249	CcSEcCtD
Pyridostigmine—Flatulence—Efavirenz—acquired immunodeficiency syndrome	0.000797	0.00249	CcSEcCtD
Pyridostigmine—Somnolence—Nevirapine—acquired immunodeficiency syndrome	0.000796	0.00249	CcSEcCtD
Pyridostigmine—Hypotension—Abacavir—acquired immunodeficiency syndrome	0.000795	0.00249	CcSEcCtD
Pyridostigmine—Epistaxis—Lamivudine—acquired immunodeficiency syndrome	0.000793	0.00248	CcSEcCtD
Pyridostigmine—Musculoskeletal discomfort—Nelfinavir—acquired immunodeficiency syndrome	0.00079	0.00247	CcSEcCtD
Pyridostigmine—Musculoskeletal discomfort—Stavudine—acquired immunodeficiency syndrome	0.000787	0.00246	CcSEcCtD
Pyridostigmine—Hypoaesthesia—Saquinavir—acquired immunodeficiency syndrome	0.000787	0.00246	CcSEcCtD
Pyridostigmine—Abdominal pain—Didanosine—acquired immunodeficiency syndrome	0.000787	0.00246	CcSEcCtD
Pyridostigmine—Agitation—Indinavir—acquired immunodeficiency syndrome	0.000787	0.00246	CcSEcCtD
Pyridostigmine—Alopecia—Delavirdine—acquired immunodeficiency syndrome	0.000785	0.00246	CcSEcCtD
Pyridostigmine—Myalgia—Zidovudine—acquired immunodeficiency syndrome	0.000783	0.00245	CcSEcCtD
Pyridostigmine—Asthenia—Amprenavir—acquired immunodeficiency syndrome	0.000783	0.00245	CcSEcCtD
Pyridostigmine—Paraesthesia—Nelfinavir—acquired immunodeficiency syndrome	0.000778	0.00243	CcSEcCtD
Pyridostigmine—Paraesthesia—Stavudine—acquired immunodeficiency syndrome	0.000776	0.00243	CcSEcCtD
Pyridostigmine—Musculoskeletal discomfort—Abacavir—acquired immunodeficiency syndrome	0.000776	0.00242	CcSEcCtD
Pyridostigmine—Somnolence—Nelfinavir—acquired immunodeficiency syndrome	0.000771	0.00241	CcSEcCtD
Pyridostigmine—Vertigo—Indinavir—acquired immunodeficiency syndrome	0.000769	0.0024	CcSEcCtD
Pyridostigmine—Somnolence—Stavudine—acquired immunodeficiency syndrome	0.000768	0.0024	CcSEcCtD
Pyridostigmine—Paraesthesia—Abacavir—acquired immunodeficiency syndrome	0.000764	0.00239	CcSEcCtD
Pyridostigmine—Flatulence—Delavirdine—acquired immunodeficiency syndrome	0.000762	0.00238	CcSEcCtD
Pyridostigmine—Confusional state—Zidovudine—acquired immunodeficiency syndrome	0.000757	0.00237	CcSEcCtD
Pyridostigmine—Loss of consciousness—Indinavir—acquired immunodeficiency syndrome	0.000752	0.00235	CcSEcCtD
Pyridostigmine—Hypoaesthesia—Lamivudine—acquired immunodeficiency syndrome	0.000751	0.00235	CcSEcCtD
Pyridostigmine—Diarrhoea—Amprenavir—acquired immunodeficiency syndrome	0.000747	0.00234	CcSEcCtD
Pyridostigmine—Muscle spasms—Delavirdine—acquired immunodeficiency syndrome	0.000744	0.00233	CcSEcCtD
Pyridostigmine—Agitation—Efavirenz—acquired immunodeficiency syndrome	0.000743	0.00232	CcSEcCtD
Pyridostigmine—Feeling abnormal—Nevirapine—acquired immunodeficiency syndrome	0.000738	0.00231	CcSEcCtD
Pyridostigmine—Hypersensitivity—Didanosine—acquired immunodeficiency syndrome	0.000733	0.00229	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Nevirapine—acquired immunodeficiency syndrome	0.000732	0.00229	CcSEcCtD
Pyridostigmine—Myalgia—Indinavir—acquired immunodeficiency syndrome	0.000729	0.00228	CcSEcCtD
Pyridostigmine—Vertigo—Efavirenz—acquired immunodeficiency syndrome	0.000727	0.00227	CcSEcCtD
Pyridostigmine—Hyperhidrosis—Zidovudine—acquired immunodeficiency syndrome	0.000726	0.00227	CcSEcCtD
Pyridostigmine—Feeling abnormal—Nelfinavir—acquired immunodeficiency syndrome	0.000714	0.00223	CcSEcCtD
Pyridostigmine—Asthenia—Didanosine—acquired immunodeficiency syndrome	0.000714	0.00223	CcSEcCtD
Pyridostigmine—Agitation—Delavirdine—acquired immunodeficiency syndrome	0.000711	0.00222	CcSEcCtD
Pyridostigmine—Urticaria—Nevirapine—acquired immunodeficiency syndrome	0.000711	0.00222	CcSEcCtD
Pyridostigmine—Loss of consciousness—Efavirenz—acquired immunodeficiency syndrome	0.000711	0.00222	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Nelfinavir—acquired immunodeficiency syndrome	0.000709	0.00222	CcSEcCtD
Pyridostigmine—Abdominal pain—Nevirapine—acquired immunodeficiency syndrome	0.000707	0.00221	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Stavudine—acquired immunodeficiency syndrome	0.000707	0.00221	CcSEcCtD
Pyridostigmine—Flatulence—Ritonavir—acquired immunodeficiency syndrome	0.000705	0.0022	CcSEcCtD
Pyridostigmine—Feeling abnormal—Abacavir—acquired immunodeficiency syndrome	0.000702	0.00219	CcSEcCtD
Pyridostigmine—Convulsion—Efavirenz—acquired immunodeficiency syndrome	0.000701	0.00219	CcSEcCtD
Pyridostigmine—Alopecia—Saquinavir—acquired immunodeficiency syndrome	0.000699	0.00219	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Abacavir—acquired immunodeficiency syndrome	0.000696	0.00218	CcSEcCtD
Pyridostigmine—Vertigo—Delavirdine—acquired immunodeficiency syndrome	0.000695	0.00217	CcSEcCtD
Pyridostigmine—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.000694	0.00217	CcSEcCtD
Pyridostigmine—Urticaria—Nelfinavir—acquired immunodeficiency syndrome	0.000689	0.00215	CcSEcCtD
Pyridostigmine—Myalgia—Efavirenz—acquired immunodeficiency syndrome	0.000688	0.00215	CcSEcCtD
Pyridostigmine—Rash—Amprenavir—acquired immunodeficiency syndrome	0.000688	0.00215	CcSEcCtD
Pyridostigmine—Muscle spasms—Ritonavir—acquired immunodeficiency syndrome	0.000688	0.00215	CcSEcCtD
Pyridostigmine—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.000688	0.00215	CcSEcCtD
Pyridostigmine—Urticaria—Stavudine—acquired immunodeficiency syndrome	0.000686	0.00215	CcSEcCtD
Pyridostigmine—Abdominal pain—Nelfinavir—acquired immunodeficiency syndrome	0.000685	0.00214	CcSEcCtD
Pyridostigmine—Musculoskeletal discomfort—Zidovudine—acquired immunodeficiency syndrome	0.000684	0.00214	CcSEcCtD
Pyridostigmine—Headache—Amprenavir—acquired immunodeficiency syndrome	0.000684	0.00214	CcSEcCtD
Pyridostigmine—Abdominal pain—Stavudine—acquired immunodeficiency syndrome	0.000683	0.00214	CcSEcCtD
Pyridostigmine—Diarrhoea—Didanosine—acquired immunodeficiency syndrome	0.000681	0.00213	CcSEcCtD
Pyridostigmine—Loss of consciousness—Delavirdine—acquired immunodeficiency syndrome	0.00068	0.00213	CcSEcCtD
Pyridostigmine—Flatulence—Saquinavir—acquired immunodeficiency syndrome	0.000679	0.00212	CcSEcCtD
Pyridostigmine—Urticaria—Abacavir—acquired immunodeficiency syndrome	0.000676	0.00211	CcSEcCtD
Pyridostigmine—Hyperhidrosis—Indinavir—acquired immunodeficiency syndrome	0.000675	0.00211	CcSEcCtD
Pyridostigmine—Paraesthesia—Zidovudine—acquired immunodeficiency syndrome	0.000674	0.00211	CcSEcCtD
Pyridostigmine—Abdominal pain—Abacavir—acquired immunodeficiency syndrome	0.000673	0.0021	CcSEcCtD
Pyridostigmine—Somnolence—Zidovudine—acquired immunodeficiency syndrome	0.000668	0.00209	CcSEcCtD
Pyridostigmine—Alopecia—Lamivudine—acquired immunodeficiency syndrome	0.000667	0.00208	CcSEcCtD
Pyridostigmine—Confusional state—Efavirenz—acquired immunodeficiency syndrome	0.000665	0.00208	CcSEcCtD
Pyridostigmine—Muscle spasms—Saquinavir—acquired immunodeficiency syndrome	0.000662	0.00207	CcSEcCtD
Pyridostigmine—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.000659	0.00206	CcSEcCtD
Pyridostigmine—Myalgia—Delavirdine—acquired immunodeficiency syndrome	0.000659	0.00206	CcSEcCtD
Pyridostigmine—Agitation—Ritonavir—acquired immunodeficiency syndrome	0.000657	0.00206	CcSEcCtD
Pyridostigmine—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.000649	0.00203	CcSEcCtD
Pyridostigmine—Flatulence—Lamivudine—acquired immunodeficiency syndrome	0.000647	0.00202	CcSEcCtD
Pyridostigmine—Vertigo—Ritonavir—acquired immunodeficiency syndrome	0.000643	0.00201	CcSEcCtD
Pyridostigmine—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.000642	0.00201	CcSEcCtD
Pyridostigmine—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.000639	0.002	CcSEcCtD
Pyridostigmine—Hyperhidrosis—Efavirenz—acquired immunodeficiency syndrome	0.000638	0.00199	CcSEcCtD
Pyridostigmine—Confusional state—Delavirdine—acquired immunodeficiency syndrome	0.000637	0.00199	CcSEcCtD
Pyridostigmine—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.000637	0.00199	CcSEcCtD
Pyridostigmine—Musculoskeletal discomfort—Indinavir—acquired immunodeficiency syndrome	0.000636	0.00199	CcSEcCtD
Pyridostigmine—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000633	0.00198	CcSEcCtD
Pyridostigmine—Agitation—Saquinavir—acquired immunodeficiency syndrome	0.000633	0.00198	CcSEcCtD
Pyridostigmine—Muscle spasms—Lamivudine—acquired immunodeficiency syndrome	0.000632	0.00197	CcSEcCtD
Pyridostigmine—Loss of consciousness—Ritonavir—acquired immunodeficiency syndrome	0.000629	0.00197	CcSEcCtD
Pyridostigmine—Rash—Didanosine—acquired immunodeficiency syndrome	0.000628	0.00196	CcSEcCtD
Pyridostigmine—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	0.000627	0.00196	CcSEcCtD
Pyridostigmine—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.000627	0.00196	CcSEcCtD
Pyridostigmine—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000627	0.00196	CcSEcCtD
Pyridostigmine—Headache—Didanosine—acquired immunodeficiency syndrome	0.000624	0.00195	CcSEcCtD
Pyridostigmine—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000622	0.00194	CcSEcCtD
Pyridostigmine—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.000621	0.00194	CcSEcCtD
Pyridostigmine—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.00062	0.00194	CcSEcCtD
Pyridostigmine—Convulsion—Ritonavir—acquired immunodeficiency syndrome	0.00062	0.00194	CcSEcCtD
Pyridostigmine—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.000619	0.00193	CcSEcCtD
Pyridostigmine—Vertigo—Saquinavir—acquired immunodeficiency syndrome	0.000619	0.00193	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.000614	0.00192	CcSEcCtD
Pyridostigmine—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000612	0.00191	CcSEcCtD
Pyridostigmine—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000611	0.00191	CcSEcCtD
Pyridostigmine—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.00061	0.00191	CcSEcCtD
Pyridostigmine—Myalgia—Ritonavir—acquired immunodeficiency syndrome	0.000609	0.0019	CcSEcCtD
Pyridostigmine—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.000605	0.00189	CcSEcCtD
Pyridostigmine—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000601	0.00188	CcSEcCtD
Pyridostigmine—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000597	0.00187	CcSEcCtD
Pyridostigmine—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.000597	0.00187	CcSEcCtD
Pyridostigmine—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000594	0.00186	CcSEcCtD
Pyridostigmine—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000593	0.00185	CcSEcCtD
Pyridostigmine—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.000593	0.00185	CcSEcCtD
Pyridostigmine—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000591	0.00185	CcSEcCtD
Pyridostigmine—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000591	0.00185	CcSEcCtD
Pyridostigmine—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.00059	0.00185	CcSEcCtD
Pyridostigmine—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.00059	0.00184	CcSEcCtD
Pyridostigmine—Confusional state—Ritonavir—acquired immunodeficiency syndrome	0.000589	0.00184	CcSEcCtD
Pyridostigmine—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000587	0.00183	CcSEcCtD
Pyridostigmine—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.000586	0.00183	CcSEcCtD
Pyridostigmine—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000582	0.00182	CcSEcCtD
Pyridostigmine—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.000577	0.00181	CcSEcCtD
Pyridostigmine—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000576	0.0018	CcSEcCtD
Pyridostigmine—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000575	0.0018	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000571	0.00179	CcSEcCtD
Pyridostigmine—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.000569	0.00178	CcSEcCtD
Pyridostigmine—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000569	0.00178	CcSEcCtD
Pyridostigmine—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000567	0.00177	CcSEcCtD
Pyridostigmine—Confusional state—Saquinavir—acquired immunodeficiency syndrome	0.000567	0.00177	CcSEcCtD
Pyridostigmine—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.000564	0.00176	CcSEcCtD
Pyridostigmine—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000564	0.00176	CcSEcCtD
Pyridostigmine—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000564	0.00176	CcSEcCtD
Pyridostigmine—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000561	0.00176	CcSEcCtD
Pyridostigmine—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000561	0.00175	CcSEcCtD
Pyridostigmine—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.000559	0.00175	CcSEcCtD
Pyridostigmine—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000555	0.00173	CcSEcCtD
Pyridostigmine—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000552	0.00173	CcSEcCtD
Pyridostigmine—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000551	0.00172	CcSEcCtD
Pyridostigmine—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000549	0.00172	CcSEcCtD
Pyridostigmine—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000547	0.00171	CcSEcCtD
Pyridostigmine—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000546	0.00171	CcSEcCtD
Pyridostigmine—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.000546	0.00171	CcSEcCtD
Pyridostigmine—Rash—Stavudine—acquired immunodeficiency syndrome	0.000545	0.0017	CcSEcCtD
Pyridostigmine—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000544	0.0017	CcSEcCtD
Pyridostigmine—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000544	0.0017	CcSEcCtD
Pyridostigmine—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000543	0.0017	CcSEcCtD
Pyridostigmine—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000543	0.0017	CcSEcCtD
Pyridostigmine—Headache—Stavudine—acquired immunodeficiency syndrome	0.000541	0.00169	CcSEcCtD
Pyridostigmine—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000541	0.00169	CcSEcCtD
Pyridostigmine—Confusional state—Lamivudine—acquired immunodeficiency syndrome	0.000541	0.00169	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.00054	0.00169	CcSEcCtD
Pyridostigmine—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000539	0.00168	CcSEcCtD
Pyridostigmine—Rash—Abacavir—acquired immunodeficiency syndrome	0.000537	0.00168	CcSEcCtD
Pyridostigmine—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000536	0.00168	CcSEcCtD
Pyridostigmine—Headache—Abacavir—acquired immunodeficiency syndrome	0.000533	0.00167	CcSEcCtD
Pyridostigmine—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000532	0.00166	CcSEcCtD
Pyridostigmine—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000532	0.00166	CcSEcCtD
Pyridostigmine—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.000525	0.00164	CcSEcCtD
Pyridostigmine—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000524	0.00164	CcSEcCtD
Pyridostigmine—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000524	0.00164	CcSEcCtD
Pyridostigmine—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000522	0.00163	CcSEcCtD
Pyridostigmine—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.00052	0.00163	CcSEcCtD
Pyridostigmine—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.000519	0.00162	CcSEcCtD
Pyridostigmine—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.000518	0.00162	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000516	0.00161	CcSEcCtD
Pyridostigmine—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000515	0.00161	CcSEcCtD
Pyridostigmine—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000515	0.00161	CcSEcCtD
Pyridostigmine—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000514	0.00161	CcSEcCtD
Pyridostigmine—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000513	0.0016	CcSEcCtD
Pyridostigmine—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000512	0.0016	CcSEcCtD
Pyridostigmine—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000506	0.00158	CcSEcCtD
Pyridostigmine—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.000505	0.00158	CcSEcCtD
Pyridostigmine—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000502	0.00157	CcSEcCtD
Pyridostigmine—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000501	0.00157	CcSEcCtD
Pyridostigmine—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.000501	0.00157	CcSEcCtD
Pyridostigmine—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.0005	0.00156	CcSEcCtD
Pyridostigmine—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000499	0.00156	CcSEcCtD
Pyridostigmine—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000488	0.00153	CcSEcCtD
Pyridostigmine—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000486	0.00152	CcSEcCtD
Pyridostigmine—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.000481	0.00151	CcSEcCtD
Pyridostigmine—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000481	0.0015	CcSEcCtD
Pyridostigmine—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000478	0.00149	CcSEcCtD
Pyridostigmine—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000478	0.00149	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000477	0.00149	CcSEcCtD
Pyridostigmine—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000477	0.00149	CcSEcCtD
Pyridostigmine—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000474	0.00148	CcSEcCtD
Pyridostigmine—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000474	0.00148	CcSEcCtD
Pyridostigmine—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000473	0.00148	CcSEcCtD
Pyridostigmine—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000471	0.00147	CcSEcCtD
Pyridostigmine—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000465	0.00145	CcSEcCtD
Pyridostigmine—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000464	0.00145	CcSEcCtD
Pyridostigmine—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.000463	0.00145	CcSEcCtD
Pyridostigmine—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000462	0.00144	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.00046	0.00144	CcSEcCtD
Pyridostigmine—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000453	0.00142	CcSEcCtD
Pyridostigmine—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000452	0.00141	CcSEcCtD
Pyridostigmine—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000446	0.0014	CcSEcCtD
Pyridostigmine—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000446	0.00139	CcSEcCtD
Pyridostigmine—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000444	0.00139	CcSEcCtD
Pyridostigmine—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000444	0.00139	CcSEcCtD
Pyridostigmine—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.000442	0.00138	CcSEcCtD
Pyridostigmine—Rash—Indinavir—acquired immunodeficiency syndrome	0.00044	0.00138	CcSEcCtD
Pyridostigmine—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.00044	0.00138	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000438	0.00137	CcSEcCtD
Pyridostigmine—Headache—Indinavir—acquired immunodeficiency syndrome	0.000438	0.00137	CcSEcCtD
Pyridostigmine—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000432	0.00135	CcSEcCtD
Pyridostigmine—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.00043	0.00135	CcSEcCtD
Pyridostigmine—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000426	0.00133	CcSEcCtD
Pyridostigmine—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000424	0.00133	CcSEcCtD
Pyridostigmine—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.00042	0.00131	CcSEcCtD
Pyridostigmine—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000419	0.00131	CcSEcCtD
Pyridostigmine—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000416	0.0013	CcSEcCtD
Pyridostigmine—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000416	0.0013	CcSEcCtD
Pyridostigmine—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000415	0.0013	CcSEcCtD
Pyridostigmine—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000414	0.00129	CcSEcCtD
Pyridostigmine—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000413	0.00129	CcSEcCtD
Pyridostigmine—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000403	0.00126	CcSEcCtD
Pyridostigmine—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000401	0.00126	CcSEcCtD
Pyridostigmine—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.0004	0.00125	CcSEcCtD
Pyridostigmine—BCHE—blood plasma—acquired immunodeficiency syndrome	0.000398	0.128	CbGeAlD
Pyridostigmine—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000398	0.00124	CcSEcCtD
Pyridostigmine—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000398	0.00124	CcSEcCtD
Pyridostigmine—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000396	0.00124	CcSEcCtD
Pyridostigmine—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000395	0.00123	CcSEcCtD
Pyridostigmine—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000392	0.00123	CcSEcCtD
Pyridostigmine—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000385	0.0012	CcSEcCtD
Pyridostigmine—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000385	0.0012	CcSEcCtD
Pyridostigmine—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000375	0.00117	CcSEcCtD
Pyridostigmine—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000371	0.00116	CcSEcCtD
Pyridostigmine—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000368	0.00115	CcSEcCtD
Pyridostigmine—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000368	0.00115	CcSEcCtD
Pyridostigmine—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000367	0.00115	CcSEcCtD
Pyridostigmine—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000366	0.00114	CcSEcCtD
Pyridostigmine—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000357	0.00112	CcSEcCtD
Pyridostigmine—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000354	0.00111	CcSEcCtD
Pyridostigmine—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000354	0.00111	CcSEcCtD
Pyridostigmine—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000352	0.0011	CcSEcCtD
Pyridostigmine—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000347	0.00108	CcSEcCtD
Pyridostigmine—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000341	0.00107	CcSEcCtD
Pyridostigmine—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000338	0.00106	CcSEcCtD
Pyridostigmine—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000338	0.00106	CcSEcCtD
Pyridostigmine—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000336	0.00105	CcSEcCtD
Pyridostigmine—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000334	0.00104	CcSEcCtD
Pyridostigmine—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000318	0.000996	CcSEcCtD
Pyridostigmine—ACHE—spinal cord—acquired immunodeficiency syndrome	0.000286	0.0917	CbGeAlD
Pyridostigmine—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.000268	0.086	CbGeAlD
Pyridostigmine—BCHE—skin of body—acquired immunodeficiency syndrome	0.000191	0.0614	CbGeAlD
Pyridostigmine—ACHE—brain—acquired immunodeficiency syndrome	0.000184	0.0591	CbGeAlD
Pyridostigmine—ACHE—lymph node—acquired immunodeficiency syndrome	0.000178	0.0571	CbGeAlD
Pyridostigmine—BCHE—digestive system—acquired immunodeficiency syndrome	0.000153	0.0491	CbGeAlD
Pyridostigmine—BCHE—blood—acquired immunodeficiency syndrome	0.000146	0.0468	CbGeAlD
Pyridostigmine—BCHE—bone marrow—acquired immunodeficiency syndrome	0.000141	0.0453	CbGeAlD
Pyridostigmine—BCHE—spinal cord—acquired immunodeficiency syndrome	0.000141	0.0451	CbGeAlD
Pyridostigmine—BCHE—vagina—acquired immunodeficiency syndrome	0.000135	0.0434	CbGeAlD
Pyridostigmine—BCHE—lung—acquired immunodeficiency syndrome	0.000128	0.041	CbGeAlD
Pyridostigmine—BCHE—nervous system—acquired immunodeficiency syndrome	0.000118	0.038	CbGeAlD
Pyridostigmine—BCHE—central nervous system—acquired immunodeficiency syndrome	0.000114	0.0366	CbGeAlD
Pyridostigmine—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000103	0.0331	CbGeAlD
Pyridostigmine—CYP3A4—blood—acquired immunodeficiency syndrome	9.82e-05	0.0315	CbGeAlD
Pyridostigmine—BCHE—brain—acquired immunodeficiency syndrome	9.05e-05	0.029	CbGeAlD
Pyridostigmine—BCHE—lymph node—acquired immunodeficiency syndrome	8.75e-05	0.0281	CbGeAlD
Pyridostigmine—CYP3A4—nervous system—acquired immunodeficiency syndrome	7.97e-05	0.0256	CbGeAlD
Pyridostigmine—CYP3A4—central nervous system—acquired immunodeficiency syndrome	7.68e-05	0.0246	CbGeAlD
